Cargando…

Questionnaire-based Pan-India survey for impact assessment of National Formulary of India

OBJECTIVES: The National Formulary of India (NFI), a ready reckoner for medicines among healthcare-professionals aims for promoting rational drug use. This needs periodic update based on evidence-based medicines and suggestions from end-users. This study assessed the level of awareness among health-...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarangi, Sudhir Chandra, Medhi, Bikash, Prakash, Ajay, Prakash, Jai, Gupta, Yogendra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265414/
https://www.ncbi.nlm.nih.gov/pubmed/34100395
http://dx.doi.org/10.4103/ijp.ijp_353_21
_version_ 1783719759796240384
author Sarangi, Sudhir Chandra
Medhi, Bikash
Prakash, Ajay
Prakash, Jai
Gupta, Yogendra K.
author_facet Sarangi, Sudhir Chandra
Medhi, Bikash
Prakash, Ajay
Prakash, Jai
Gupta, Yogendra K.
author_sort Sarangi, Sudhir Chandra
collection PubMed
description OBJECTIVES: The National Formulary of India (NFI), a ready reckoner for medicines among healthcare-professionals aims for promoting rational drug use. This needs periodic update based on evidence-based medicines and suggestions from end-users. This study assessed the level of awareness among health-care professionals and sought suggestions for enhancement of utility/content of NFI. MATERIALS AND METHODS: This pan-India cross-sectional, questionnaire-based survey was conducted between November-2020 and March-2021. A Google-doc-based validated questionnaire (20 questions) was circulated through E-mail/social media groups and to 311 medical institutes/hospitals/clinics across India through the adverse drug reaction monitoring centers under the Pharmacovigilance Program of India. RESULTS: A total of 461 participants (39-interns, 167-resident doctors, and the rest practicing physicians/doctors) affiliated to 224 institutes/hospitals/clinics had responded. About 46% respondents consulted NFI for drug-related information and 82.3% stated that NFI provides balanced unbiased information. About 95% respondents were aware of NFI's content and 76% mentioned usefulness of NFI in their clinical practice; however, 34.4% had misconceptions about NFI, 28.7% had a false belief that NFI is a legal document to safeguard health-care providers and 22.2% had never used it. Suggestions to enhance NFI's utility included digital accessibility, incorporation of information like drugs for basic medical emergencies (71.3%), disposal of expired-pharmaceutical products (38.7%), pharmaceutical price control policy (36.3%), and drug-procurement practices in hospitals (35.6%). CONCLUSION: As per the survey findings, NFI is an effective tool for instant access to precise and unbiased drug-related information, and fostering rational use of drugs. Boosting its practical usefulness needs incorporation of suggested information, digital accessibility, and periodic update.
format Online
Article
Text
id pubmed-8265414
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-82654142021-07-16 Questionnaire-based Pan-India survey for impact assessment of National Formulary of India Sarangi, Sudhir Chandra Medhi, Bikash Prakash, Ajay Prakash, Jai Gupta, Yogendra K. Indian J Pharmacol Research Article OBJECTIVES: The National Formulary of India (NFI), a ready reckoner for medicines among healthcare-professionals aims for promoting rational drug use. This needs periodic update based on evidence-based medicines and suggestions from end-users. This study assessed the level of awareness among health-care professionals and sought suggestions for enhancement of utility/content of NFI. MATERIALS AND METHODS: This pan-India cross-sectional, questionnaire-based survey was conducted between November-2020 and March-2021. A Google-doc-based validated questionnaire (20 questions) was circulated through E-mail/social media groups and to 311 medical institutes/hospitals/clinics across India through the adverse drug reaction monitoring centers under the Pharmacovigilance Program of India. RESULTS: A total of 461 participants (39-interns, 167-resident doctors, and the rest practicing physicians/doctors) affiliated to 224 institutes/hospitals/clinics had responded. About 46% respondents consulted NFI for drug-related information and 82.3% stated that NFI provides balanced unbiased information. About 95% respondents were aware of NFI's content and 76% mentioned usefulness of NFI in their clinical practice; however, 34.4% had misconceptions about NFI, 28.7% had a false belief that NFI is a legal document to safeguard health-care providers and 22.2% had never used it. Suggestions to enhance NFI's utility included digital accessibility, incorporation of information like drugs for basic medical emergencies (71.3%), disposal of expired-pharmaceutical products (38.7%), pharmaceutical price control policy (36.3%), and drug-procurement practices in hospitals (35.6%). CONCLUSION: As per the survey findings, NFI is an effective tool for instant access to precise and unbiased drug-related information, and fostering rational use of drugs. Boosting its practical usefulness needs incorporation of suggested information, digital accessibility, and periodic update. Wolters Kluwer - Medknow 2021 2021-05-26 /pmc/articles/PMC8265414/ /pubmed/34100395 http://dx.doi.org/10.4103/ijp.ijp_353_21 Text en Copyright: © 2021 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Sarangi, Sudhir Chandra
Medhi, Bikash
Prakash, Ajay
Prakash, Jai
Gupta, Yogendra K.
Questionnaire-based Pan-India survey for impact assessment of National Formulary of India
title Questionnaire-based Pan-India survey for impact assessment of National Formulary of India
title_full Questionnaire-based Pan-India survey for impact assessment of National Formulary of India
title_fullStr Questionnaire-based Pan-India survey for impact assessment of National Formulary of India
title_full_unstemmed Questionnaire-based Pan-India survey for impact assessment of National Formulary of India
title_short Questionnaire-based Pan-India survey for impact assessment of National Formulary of India
title_sort questionnaire-based pan-india survey for impact assessment of national formulary of india
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265414/
https://www.ncbi.nlm.nih.gov/pubmed/34100395
http://dx.doi.org/10.4103/ijp.ijp_353_21
work_keys_str_mv AT sarangisudhirchandra questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia
AT medhibikash questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia
AT prakashajay questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia
AT prakashjai questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia
AT guptayogendrak questionnairebasedpanindiasurveyforimpactassessmentofnationalformularyofindia